Le Lézard
Classified in: Covid-19 virus
Subjects: Event, Award, Webcast

Giants of Cancer Care® 2020 Awards Ceremony Will Be Held Virtually in November


Because of global concern regarding the COVID-19 outbreak, OncLive® announces the Eighth Annual Giants of Cancer Care® awards ceremony will be held virtually on Thursday, Nov. 5, at 7.30 p.m. EST.

"The health and safety of our attendees is of the utmost importance to OncLive®, and that is why we have made the difficult decision to transition our annual awards ceremony to a virtual format," said Mike Hennessy Jr., president, and CEO of MJH Life Sciencestm, parent company of OncLive®. "We look forward to recognizing each of these outstanding individuals at this year's Giants of Cancer Care® celebration."

The Giants of Cancer Care® recognition program celebrates the achievements of leading researchers and educators whose discoveries have helped propel the field forward and established the building blocks for future advances.

Members of the Giants of Cancer Care® advisory board selected semifinalists from the hundreds of nominations submitted. A selection committee of more than 120 eminent oncologists then chose honorees from several types of tumor and specialty categories. The 2020 inductees will be announced in September.

For more information and to register, click here.

Supporters of the 2020 program include Athenex, Incyte, and Pfizer.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive® is a brand of MJH Life Sciencestm, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

About Giants of Cancer Care®

Giants of Cancer Care® celebrates the achievements of leading researchers and educators whose discoveries have helped propel the field of oncology and established the building blocks for future advances. Every year, a selection committee of more than 120 eminent oncologists, researchers and clinicians chooses honorees from several types of tumor and specialty categories.


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

28 mar 2024
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...



News published on and distributed by: